Imaging of tumor-associated macrophage dynamics during immunotherapy using a CD163-specific nanobody-based immunotracer.

Autor: Lauwers Y; Molecular Imaging and Therapy Research Group, Vrije Universiteit Brussel, Brussels 1090, Belgium., De Groof TWM; Molecular Imaging and Therapy Research Group, Vrije Universiteit Brussel, Brussels 1090, Belgium., Vincke C; Laboratory of Myeloid Cell Immunology, Vlaams Instituut voor Biotechnologie Center for Inflammation Research, Brussels 1050, Belgium.; Laboratory of Cellular and Molecular Immunology, Brussels Center for Immunology, Vrije Universiteit Brussel, Brussels 1050, Belgium., Van Craenenbroeck J; Laboratory of Myeloid Cell Immunology, Vlaams Instituut voor Biotechnologie Center for Inflammation Research, Brussels 1050, Belgium.; Laboratory of Cellular and Molecular Immunology, Brussels Center for Immunology, Vrije Universiteit Brussel, Brussels 1050, Belgium., Jumapili NA; Laboratory of Myeloid Cell Immunology, Vlaams Instituut voor Biotechnologie Center for Inflammation Research, Brussels 1050, Belgium.; Laboratory of Cellular and Molecular Immunology, Brussels Center for Immunology, Vrije Universiteit Brussel, Brussels 1050, Belgium., Barthelmess RM; Laboratory of Myeloid Cell Immunology, Vlaams Instituut voor Biotechnologie Center for Inflammation Research, Brussels 1050, Belgium.; Laboratory of Cellular and Molecular Immunology, Brussels Center for Immunology, Vrije Universiteit Brussel, Brussels 1050, Belgium., Courtoy G; Department of Pathology, Universitair Ziekenhuis Brussel, Brussels B-1090, Belgium.; Laboratory of Experimental Pathology, Supporting Clinical Sciences, Vrije Universiteit Brussel, Brussels B-1090, Belgium., Waelput W; Department of Pathology, Universitair Ziekenhuis Brussel, Brussels B-1090, Belgium.; Laboratory of Experimental Pathology, Supporting Clinical Sciences, Vrije Universiteit Brussel, Brussels B-1090, Belgium., De Pauw T; Molecular Imaging and Therapy Research Group, Vrije Universiteit Brussel, Brussels 1090, Belgium., Raes G; Laboratory of Myeloid Cell Immunology, Vlaams Instituut voor Biotechnologie Center for Inflammation Research, Brussels 1050, Belgium.; Laboratory of Cellular and Molecular Immunology, Brussels Center for Immunology, Vrije Universiteit Brussel, Brussels 1050, Belgium., Devoogdt N; Molecular Imaging and Therapy Research Group, Vrije Universiteit Brussel, Brussels 1090, Belgium., Van Ginderachter JA; Laboratory of Myeloid Cell Immunology, Vlaams Instituut voor Biotechnologie Center for Inflammation Research, Brussels 1050, Belgium.; Laboratory of Cellular and Molecular Immunology, Brussels Center for Immunology, Vrije Universiteit Brussel, Brussels 1050, Belgium.

Publikováno v: Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2024 Dec 24; Vol. 121 (52), pp. e2409668121. Date of Electronic Publication: 2024 Dec 18.

Broad Protection against Invasive Fungal Disease from a Nanobody Targeting the Active Site of Fungal β-1,3-Glucanosyltransferases.

Autor: Redrado-Hernández S; Instituto de Carboquímica ICB-CSIC, 50018, Zaragoza, Spain.; Center for Biomedical Research in Network in Infectious Diseases (CIBERINFEC), Health Institute Carlos III, 28029, Madrid, Spain., Macías-León J; Institute of Biocomputation and Physics of Complex Systems (BIFI), University of Zaragoza, Mariano Esquillor s/n, Campus Rio Ebro, Edificio I+D, 50018, Zaragoza, Spain., Castro-López J; Institute of Biocomputation and Physics of Complex Systems (BIFI), University of Zaragoza, Mariano Esquillor s/n, Campus Rio Ebro, Edificio I+D, 50018, Zaragoza, Spain., Belén Sanz A; Departamento de Microbiología y Parasitología, Facultad de Farmacia, Universidad Complutense de Madrid, 28040, Madrid, Spain., Dolader E; Department of Microbiology, Pediatry, Radiology and Public Health, University of Zaragoza, 50009, Zaragoza, Spain.; Aragón Health Research Institute (IIS Aragón), Biomedical Research Centre of Aragón (CIBA), 50009, Zaragoza, Spain., Arias M; Center for Biomedical Research in Network in Infectious Diseases (CIBERINFEC), Health Institute Carlos III, 28029, Madrid, Spain.; Department of Microbiology, Pediatry, Radiology and Public Health, University of Zaragoza, 50009, Zaragoza, Spain.; Aragón Health Research Institute (IIS Aragón), Biomedical Research Centre of Aragón (CIBA), 50009, Zaragoza, Spain., González-Ramírez AM; Institute of Biocomputation and Physics of Complex Systems (BIFI), University of Zaragoza, Mariano Esquillor s/n, Campus Rio Ebro, Edificio I+D, 50018, Zaragoza, Spain., Sánchez-Navarro D; Institute of Biocomputation and Physics of Complex Systems (BIFI), University of Zaragoza, Mariano Esquillor s/n, Campus Rio Ebro, Edificio I+D, 50018, Zaragoza, Spain., Petryk Y; Departamento de Microbiología y Parasitología, Facultad de Farmacia, Universidad Complutense de Madrid, 28040, Madrid, Spain., Farkaš V; Department of Glycobiology, Institute of Chemistry, Center for Glycomics, Slovak Academy of Sciences, 84538, Bratislava, Slovakia., Vincke C; Laboratory of Cellular and Molecular Immunology, Vrije Universiteit Brussel, 1050, Brussels, Belgium., Muyldermans S; Laboratory of Cellular and Molecular Immunology, Vrije Universiteit Brussel, 1050, Brussels, Belgium., García-Barbazán I; Mycology Reference Laboratory. National Centre for Microbiology., Health Institute Carlos III, 28220, Majadahonda, Madrid, Spain., Del Agua C; Aragón Health Research Institute (IIS Aragón), Biomedical Research Centre of Aragón (CIBA), 50009, Zaragoza, Spain.; Department of Pathology, Hospital Clínico Universitario Lozano Blesa, IIS-Aragón, 50009, Zaragoza, Spain., Zaragoza O; Center for Biomedical Research in Network in Infectious Diseases (CIBERINFEC), Health Institute Carlos III, 28029, Madrid, Spain.; Mycology Reference Laboratory. National Centre for Microbiology., Health Institute Carlos III, 28220, Majadahonda, Madrid, Spain., Arroyo J; Departamento de Microbiología y Parasitología, Facultad de Farmacia, Universidad Complutense de Madrid, 28040, Madrid, Spain., Pardo J; Center for Biomedical Research in Network in Infectious Diseases (CIBERINFEC), Health Institute Carlos III, 28029, Madrid, Spain.; Department of Microbiology, Pediatry, Radiology and Public Health, University of Zaragoza, 50009, Zaragoza, Spain.; Aragón Health Research Institute (IIS Aragón), Biomedical Research Centre of Aragón (CIBA), 50009, Zaragoza, Spain., Gálvez EM; Instituto de Carboquímica ICB-CSIC, 50018, Zaragoza, Spain.; Center for Biomedical Research in Network in Infectious Diseases (CIBERINFEC), Health Institute Carlos III, 28029, Madrid, Spain., Hurtado-Guerrero R; Institute of Biocomputation and Physics of Complex Systems (BIFI), University of Zaragoza, Mariano Esquillor s/n, Campus Rio Ebro, Edificio I+D, 50018, Zaragoza, Spain.; Fundación ARAID, 50018, Zaragoza, Spain.; Copenhagen Center for Glycomics, Department of Cellular and Molecular Medicine, University of Copenhagen, DK-2200, Copenhagen, Denmark.

Publikováno v: Angewandte Chemie (International ed. in English) [Angew Chem Int Ed Engl] 2024 Aug 19; Vol. 63 (34), pp. e202405823. Date of Electronic Publication: 2024 Jul 22.

Combinatorial Design of a Nanobody that Specifically Targets Structured RNAs

Autor: Cawez, F., Duray, E., Hu, Y., Vandenameele, J., Romão, E., Vincke, C., Dumoulin, M., Galleni, M., Muyldermans, S., Vandevenne, M.

Publikováno v: In Journal of Molecular Biology 25 May 2018 430(11):1652-1670

How does forest cover impact water flows and ecosystem services? Insights from “real-life” catchments in Wallonia (Belgium)

Autor: Brogna, D., Vincke, C., Brostaux, Y., Soyeurt, H., Dufrêne, M., Dendoncker, N.

Publikováno v: In Ecological Indicators January 2017 72:675-685

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.